Tudisco, Riccardo
 Distribuzione geografica
Continente #
EU - Europa 112
NA - Nord America 85
AS - Asia 83
SA - Sud America 22
AF - Africa 4
Totale 306
Nazione #
US - Stati Uniti d'America 84
IT - Italia 32
CN - Cina 31
SE - Svezia 23
SG - Singapore 22
BR - Brasile 20
DE - Germania 17
IN - India 12
FR - Francia 10
IE - Irlanda 8
ID - Indonesia 6
FI - Finlandia 5
GB - Regno Unito 5
KR - Corea 4
CZ - Repubblica Ceca 3
RU - Federazione Russa 3
AT - Austria 2
CI - Costa d'Avorio 2
HK - Hong Kong 2
AZ - Azerbaigian 1
CH - Svizzera 1
CO - Colombia 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SN - Senegal 1
TR - Turchia 1
UA - Ucraina 1
Totale 306
Città #
Singapore 18
Chandler 13
Hyderabad 9
Dublin 8
Munich 7
New York 7
Ashburn 6
Jakarta 6
Naples 6
Beijing 5
Hefei 4
Seoul 4
Helsinki 3
Marseille 3
Milan 3
Nuremberg 3
Rome 3
São Paulo 3
Abidjan 2
Bexley 2
Boston 2
Bremen 2
Campinas 2
Frankfurt am Main 2
Hong Kong 2
Los Angeles 2
Newark 2
Princeton 2
Roubaix 2
San Mateo 2
Seattle 2
Seregno 2
Shenyang 2
The Dalles 2
Turku 2
Athens 1
Baku 1
Barreiras 1
Barreiros 1
Bern 1
Bishkek 1
Brno 1
Brooklyn 1
Cambridge 1
Campos Novos 1
Changsha 1
Chennai 1
Collierville 1
Cuauhtémoc 1
Dakar 1
Daldale 1
Diadema 1
Divinópolis 1
Düsseldorf 1
Fairfield 1
Garanhuns 1
Huzhou 1
Indaiatuba 1
Juiz de Fora 1
Laranjal Paulista 1
Lima 1
London 1
Manchester 1
Moscow 1
Muscat 1
North Bergen 1
Novoiavorivsk 1
Oggiono 1
Olomouc 1
Passo de Camaragibe 1
Portland 1
Portsmouth 1
Prague 1
Praia Grande 1
Providence 1
Pune 1
Queens 1
Rabat 1
Rio de Janeiro 1
Salt Lake City 1
Serra Talhada 1
Sobradinho 1
Tel Aviv 1
Teresina 1
Vienna 1
Wilmington 1
Woodbridge 1
Totale 197
Nome #
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score 71
What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study 58
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response 58
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: A phase II, open label multicenter study (NUVOLA trial) 54
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer 39
Impact of mRNA-based vaccines in the prevention of adverse outcomes of COVID-19 infection in pregnancy: a single-center cohort study 32
Totale 312
Categoria #
all - tutte 2.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 1 0 1 0 0 0 0 0 1 1 0 0
2021/202217 0 0 0 3 1 0 1 3 0 0 3 6
2022/202371 5 6 3 5 13 8 6 6 12 1 3 3
2023/202475 6 12 3 5 2 8 7 3 6 5 5 13
2024/2025139 1 0 10 11 9 5 2 6 26 19 34 16
Totale 312